×
News Home

Should You Buy AbbVie Inc (ABBV) Stock Tuesday?

Tuesday, October 04, 2022 02:28 PM | InvestorsObserver Analysts
Should You Buy AbbVie Inc (ABBV) Stock Tuesday?

AbbVie Inc (ABBV) receives a weak valuation ranking of 14 from InvestorsObserver data analysis. The proprietary ranking system focuses on the underlying health of a company through analysis of its stock price, earnings, and growth rate. ABBV has a better value than 14% of stocks based on these valuation analytics. Investors primarily focused on buy-and-hold strategies will find the valuation ranking relevant to their goals when making investment decisions.

Valuation Rank - 14
ABBV gets a 14 Valuation Rank today. Find out what this means to you and get the rest of the rankings on ABBV!

Metrics Analysis

ABBV has a trailing twelve month Price to Earnings (PE) ratio of 19.6 which places it around the histroical average of roughly 15. ABBV is currently trading at a average value due to investors paying around what the stock is worth in relation to its earnings. ABBV's trailing-12-month earnings per share (EPS) of 7.06 does justify its share price in the market. Trailing PE ratios do not factor in the company's projected growth rate, thus, some firms will have high PE ratios caused by high growth recruiting more investors even if the underlying company has produced low earnings so far.
ABBV's 12-month-forward PE to Growth (PEG) ratio of 4.01 is considered a poor value as the market is overvaluing ABBV in relation to the company's projected earnings growth due. ABBV's PEG comes from its forward price to earnings ratio being divided by its growth rate. A PEG ratio of 1 represents a perfect correlation between earnings growth and share price. Due to their incorporation of more fundamentals of a company's overall health and focusing on the future rather than the past, PEG ratios are one of the most used valuation metrics by analysts today.

Summary

All together these valuation metrics paint a pretty poor picture for ABBV at its current price due to a overvalued PEG ratio due to strong growth. The PE and PEG for ABBV are worse than the average of the market resulting in a valuation score of 14. Click Here to get the full Report on AbbVie Inc (ABBV) stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App